AKT1 and B-cell chronic lymphocytic leukemia: The MyD88-independent pathways of CD180 signaling under pathologic conditions has only been investigated in chronic lymphocytic leukemia cells showing the activation of BTK/PI3K/AKT or p38 MAPK pathways [17].